TSHA 424B5: Secondary offering
Filed with the SEC on · accession 0001193125-26-282846
TSHA filed a 424B5 (prospectus (offering)) with the SEC on Jun 25, 2026. The final terms of an offering of shares or bonds. The stock moved -10.5% by the first close after the filing.
Summary of the filing
Taysha Gene Therapies is offering 32,500,001 shares of common stock and pre-funded warrants to purchase up to 833,333 shares at a public offering price of $6.00 per share, with total proceeds to the company of approximately $188 million before expenses.
Key details
How TSHA stock reacted
Close before
$6.94
Jun 24, 2026
First close after
-10.52%
$6.21
5 trading days
-4.18%
$6.65
Since filing
-37.61%
$4.33
✦ Ask GOAX AI about this filing — what it means for TSHA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TSHA?
Click hereFrequently asked questions
What did TSHA file with the SEC on Jun 25, 2026?
TSHA filed a 424B5 (Secondary offering). Taysha Gene Therapies is offering 32,500,001 shares of common stock and pre-funded warrants to purchase up to 833,333 shares at a public offering price of $6.00 per share, with total proceeds to the company of approximately $188 million before expenses.
What does a secondary offering mean for TSHA stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did TSHA stock react to this filing?
TSHA closed at $6.94 before the filing and $6.21 on Jun 25, 2026 (-10.52%). Five trading days later: $6.65 (-4.18%).
Other TSHA SEC filings
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 144 · Insider sale plannedJul 10, 2026
- 8-K · Secondary offeringJun 25, 2026
- 424B5 · Secondary offeringJun 24, 2026
- 8-K · Fda approvalJun 22, 2026
- 8-K · SEC filingJun 2, 2026
- 8-K · SEC filingMay 6, 2026
Get alerts when TSHA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days